Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 351

1.

A double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients.

Kiev A, Feiger A.

J Clin Psychiatry. 1997 Apr;58(4):146-52.

PMID:
9164424
[PubMed - indexed for MEDLINE]
2.

Effectiveness of low doses of paroxetine controlled release in the treatment of major depressive disorder.

Trivedi MH, Pigotti TA, Perera P, Dillingham KE, Carfagno ML, Pitts CD.

J Clin Psychiatry. 2004 Oct;65(10):1356-64.

PMID:
15491239
[PubMed - indexed for MEDLINE]
3.

A double-blind, multicenter study in primary care comparing paroxetine and clomipramine in patients with depression and associated anxiety. Paroxetine Study Group.

Ravindran AV, Judge R, Hunter BN, Bray J, Morton NH.

J Clin Psychiatry. 1997 Mar;58(3):112-8.

PMID:
9108813
[PubMed - indexed for MEDLINE]
4.

Paroxetine versus placebo: a double-blind comparison in depressed patients.

Claghorn JL, Kiev A, Rickels K, Smith WT, Dunbar GC.

J Clin Psychiatry. 1992 Dec;53(12):434-8.

PMID:
1487471
[PubMed - indexed for MEDLINE]
5.

Bupropion sustained release versus paroxetine for the treatment of depression in the elderly.

Weihs KL, Settle EC Jr, Batey SR, Houser TL, Donahue RM, Ascher JA.

J Clin Psychiatry. 2000 Mar;61(3):196-202.

PMID:
10817105
[PubMed - indexed for MEDLINE]
6.

Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression.

Feighner JP, Overø K.

J Clin Psychiatry. 1999 Dec;60(12):824-30.

PMID:
10665628
[PubMed - indexed for MEDLINE]
7.

Evaluation of double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients in menopause transition.

Ushiroyama T, Ikeda A, Ueki M.

J Med. 2004;35(1-6):151-62.

PMID:
18084873
[PubMed - indexed for MEDLINE]
8.

Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder. Venlafaxine 631 Study Group.

Mehtonen OP, Søgaard J, Roponen P, Behnke K.

J Clin Psychiatry. 2000 Feb;61(2):95-100.

PMID:
10732656
[PubMed - indexed for MEDLINE]
9.

Mirtazapine compared with paroxetine in major depression.

Benkert O, Szegedi A, Kohnen R.

J Clin Psychiatry. 2000 Sep;61(9):656-63.

PMID:
11030486
[PubMed - indexed for MEDLINE]
10.

Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.

Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I.

Eur Neuropsychopharmacol. 2004 Dec;14(6):457-70.

PMID:
15589385
[PubMed - indexed for MEDLINE]
11.

Venlafaxine versus fluvoxamine in the treatment of delusional depression: a pilot double-blind controlled study.

Zanardi R, Franchini L, Serretti A, Perez J, Smeraldi E.

J Clin Psychiatry. 2000 Jan;61(1):26-9.

PMID:
10695642
[PubMed - indexed for MEDLINE]
12.

Efficacy of fluvoxamine in the treatment of major depression with comorbid anxiety disorders.

Sonawalla SB, Spillmann MK, Kolsky AR, Alpert JE, Nierenberg AA, Rosenbaum JF, Fava M.

J Clin Psychiatry. 1999 Sep;60(9):580-3.

PMID:
10520975
[PubMed - indexed for MEDLINE]
13.

A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care.

Wade A, Crawford GM, Angus M, Wilson R, Hamilton L.

Int Clin Psychopharmacol. 2003 May;18(3):133-41.

PMID:
12702891
[PubMed - indexed for MEDLINE]
14.

Fluvoxamine maleate in the treatment of depression: a single-center, double-blind, placebo-controlled comparison with imipramine in outpatients.

Claghorn JL, Earl CQ, Walczak DD, Stoner KA, Wong LF, Kanter D, Houser VP.

J Clin Psychopharmacol. 1996 Apr;16(2):113-20.

PMID:
8690826
[PubMed - indexed for MEDLINE]
15.

Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients.

Kavoussi RJ, Segraves RT, Hughes AR, Ascher JA, Johnston JA.

J Clin Psychiatry. 1997 Dec;58(12):532-7.

PMID:
9448656
[PubMed - indexed for MEDLINE]
16.

A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder.

Bielski RJ, Ventura D, Chang CC.

J Clin Psychiatry. 2004 Sep;65(9):1190-6.

PMID:
15367045
[PubMed - indexed for MEDLINE]
17.

A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression.

Musselman DL, Somerset WI, Guo Y, Manatunga AK, Porter M, Penna S, Lewison B, Goodkin R, Lawson K, Lawson D, Evans DL, Nemeroff CB.

J Clin Psychiatry. 2006 Feb;67(2):288-96.

PMID:
16566626
[PubMed - indexed for MEDLINE]
18.

A comparison of paroxetine and placebo in depressed outpatients.

Dunbar GC, Claghorn JL, Kiev A, Rickels K, Smith WT.

Acta Psychiatr Scand. 1993 May;87(5):302-5.

PMID:
8517168
[PubMed - indexed for MEDLINE]
19.
20.

A multicenter double-blind comparison of nefazodone and paroxetine in the treatment of outpatients with moderate-to-severe depression.

Baldwin DS, Hawley CJ, Abed RT, Maragakis BP, Cox J, Buckingham SA, Pover GH, Ascher A.

J Clin Psychiatry. 1996;57 Suppl 2:46-52.

PMID:
8626363
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk